 |
|
|
REFERENCES
301.
Mielck F, Stephan H, Weyland A, Sonntag H: Effects
of one minimum alveolar anesthetic concentration sevoflurane on cerebral metabolism,
blood flow, and CO2
reactivity in cardiac patients. Anesth Analg 89:364–369,
1999.
302.
Mielck F, Stephan H, Buhre W, et al: Effects
of 1 MAC desflurane on cerebral metabolism, blood flow and carbon dioxide reactivity
in humans. Br J Anaesth 81:155–160, 1998.
303.
Sakabe T, Maekawa T, Fujii S, et al: Cerebral
circulation and metabolism during enflurane anesthesia in humans. Anesthesiology
59:532–536, 1983.
304.
Fraga M, Maceiras P, Rodino S, et al: The effects
of isoflurane and desflurane on intracranial pressure, cerebral perfusion pressure,
and cerebral arteriovenous oxygen content differences in normocapnic patients with
supratentorial brain tumors. Anesthesiology 98:1085–1090, 2003.
305.
Kaisti K, Metsahonkala L, Teras M, et al: Effects
of surgical levels of propofol and sevoflurane anesthesia on cerebral blood flow
in healthy subjects studied with positron emission tomography. Anesthesiology 96:1358–1370,
2002.
306.
Reinstrup P, Ryding E, Algotsson L, et al: Regional
cerebral blood flow (SPECT) during anaesthesia with isoflurane and nitrous oxide
in humans. Br J Anaesth 78:407–411, 1997.
307.
Bundgaard H, Oettingen G, Larsen K, et al: Effects
of sevoflurane on intracranial pressure, cerebral blood flow and cerebral metabolism.
Acta Anesthesiol Scand 42:621–627, 1998.
308.
Madsen J, Cold G, Hansen E, Bardrum B: The effect
of isoflurane on cerebral blood flow and metabolism in humans during craniotomy for
small supratentorial cerebral tumors. Anesthesiology 66:332–336, 1987.
309.
Ornstein E, Young W, Fleischer L, Ostapkovich
N: Desflurane and isoflurane have similar effects on cerebral blood flow in patients
with intracranial mass lesions. Anesthesiology 79:498–502, 1993.
310.
Algotsson L, Messeter K, Nordstrom C, Ryding E:
Cerebral blood flow and oxygen consumption during isoflurane and halothane anesthesia
in man. Acta Anesthesiol Scand 32:15–20, 1988.
311.
Kolbitsch C, Lorenz I, Hormann C, et al: Sevoflurane
and nitrous oxide increase regional cerebral blood flow (rCBF) and regional cerebral
blood volume (rCBV) in a drugspecific manner in human volunteers. Magn Reson Imaging
19:1253–1260, 2001.
312.
Kolbitsch C, Lorenz I, Hormann C, et al: A subanesthetic
concentration of sevoflurane increases regional cerebral blood flow and regional
cerebral blood volume and decreases regional mean transit time and regional cerebrovascular
resistance in volunteers. Anesth Analg 91:156–162, 2000.
313.
Lorenz I, Hormann C, Luger T, et al: Influence
of equianaesthetic concentrations of nitrous oxide and isoflurane on regional cerebral
blood flow, regional cerebral blood volume, and regional mean transit time in human
volunteers. Br J Anaesth 87:691–698, 2001.
314.
Alkire M, Pomfrett CJ, Haier RJ, et al: Functional
brain imaging during anesthesia in humans: Effects of halothane on global and regional
cerebral glucose metabolism. Anesthesiology 90:701–709, 1999.
315.
Young WL, Prohovnik I, Ornstein E, et al: The
effect of arteriovenous malformation resection on cerebrovascular reactivity to carbon
dioxide. Neurosurgery 27:257–267, 1990.
316.
Ornstein E, Young WL, Fleischer LH, Ostapkovich
N: Desflurane and isoflurane have similar effects on cerebral blood flow in patients
with intracranial mass lesions. Anesthesiology 79:498–502, 1993.
317.
Milde LN, Milde JH: Cerebral effects of sufentanil
in dogs with reduced intracranial compliance. Anesth Analg 68:S196, 1989.
318.
Alkire MT, Haier RJ, Shah NK, Anderson CT: Positron
emission tomography study of regional cerebral metabolism in humans during isoflurane
anesthesia. Anesthesiology 86:549–557, 1997.
319.
Rampil IJ, Lockhart SH, Eger EI, et al: The electroencephalographic
effects of desflurane in humans. Anesthesiology 74:434–439, 1991.
320.
Boarini DJ, Kassell NF, Coester HC, et al: Comparison
of systemic and cerebrovascular effects of isoflurane and halothane. Neurosurgery
15:400–409, 1984.
321.
Adams RW, Cucchiara RF, Gronert GA, et al: Isoflurane
and cerebrospinal fluid pressures in neurosurgical patients. Anesthesiology 54:97–99,
1981.
322.
Grosslight K, Foster R, Colohan AR, Bedford RF:
Isoflurane for neuroanesthesia: Risk factors for increases in intracranial pressure.
Anesthesiology 63:533–536, 1985.
323.
Campkin TV, Flinn RM: Isoflurane and cerebrospinal
fluid pressure—a study in neurosurgical patients undergoing intracranial shunt
procedures. Anaesthesia 44:50–54, 1989.
324.
Scheller MS, Todd MM, Drummond JC: A comparison
of the ICP effects of isoflurane and halothane after cryogenic brain injury in rabbits.
Anesthesiology 67:507–512, 1987.
325.
Adams RW, Gronert GA, Sundt TM, Michenfelder JD:
Halothane, hypocapnia and cerebrospinal fluid pressure in neurosurgery. Anesthesiology
37:510–517, 1972.
326.
Warner DS, Boarini DJ, Kassell NL: Cerebrovascular
adaptation to prolonged halothane anesthesia is not related to cerebrospinal fluid
pH. Anesthesiology 63:243–248, 1985.
327.
Fleischer LH, Young WL, Ornstein E, Ostapkovich
N: Cerebral blood flow in humans does not decline over time during isoflurane or
desflurane anesthesia [abstract]. Anesthesiology 77:A167, 1992.
328.
Cenic A, Craen R, Lee T, Gelb A: Cerebral blood
volume and blood flow responses to hyperventilation in brain tumors during isoflurane
or propofol anesthesia. Anesth Analg 94:661–666, 2002.
329.
Madsen JB, Cold GE, Hansen ES, Bardrum B: Cerebral
blood flow, cerebral metabolic rate of oxygen and relative CO2
-reactivity
during craniotomy for supratentorial cerebral tumours in halothane anaesthesia.
A dose-response study. Acta Anaesthesiol Scand 31:454–457, 1987.
330.
Drummond JC, Todd MM: The response of the feline
cerebral circulation to PaCO2
during anesthesia
with isoflurane and halothane and during sedation with nitrous oxide. Anesthesiology
62:268–273, 1985.
331.
Cho S, Fujigaki T, Uchiyama Y, et al: Effects
of sevoflurane with and without nitrous oxide on human cerebral circulation. Anesthesiology
85:755–760, 1996.
332.
Morita H, Bleyaert AL, Stezoski SW, Nemoto EM:
The effect of halothane anesthesia on cerebral blood flow, autoregulation and cerebral
metabolism of oxygen and glucose [abstract]. Paper presented at the Annual Meeting
of the American Society of Anesthesiologists, October 1974, pp 63–64.
333.
Strebel S, Lam AM, Matta B, et al: Dynamic and
static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia.
Anesthesiology 83:66–76, 1995.
334.
Gupta S, Heath K, Matta BF: Effect of incremental
doses of sevoflurane on cerebral pressure autoregulation in humans. Br J Anaesth
79:469–472, 1997.
335.
Vavilala MS, Lee LA, Lee M, et al: Cerebral autoregulation
in children during sevoflurane anaesthesia. Br J Anaesth 90:636–641, 2003.
336.
Lu H, Werner C, Englehard K, et al: The effects
of sevoflurane on cerebral blood flow autoregulation in rats. Anesth Analg 87:854–858,
1998.
337.
Neigh JL, Garman JK, Harp JR: The electroencephalographic
pattern during anesthesia with Enthrane. Anesthesiology 35:482–487, 1971.
338.
Wollman H, Smith AL, Hoffman JC: Cerebral blood
flow and oxygen consumption in man during electroencephalographic seizure patterns
induced by anesthesia with Ethrane [abstract]. Fed Proc 28:356, 1967.
339.
Fleming DC, Fitzpatrick J, Fariello RG, et al:
Diagnostic activation of epileptogenic foci by enflurane. Anesthesiology 52:431–433,
1980.
340.
Opitz A, Brecht S, Stenyel E: Enflurane anesthesia
in epileptics [in German]. Anaesthesist 26:329–332, 1977.
341.
Kruczek M, Albin MS, Wolf S, Bertoni JM: Postoperative
seizure activity following enflurane anesthesia. Anesthesiology 53:175–176,
1980.
342.
Hymes JA: Seizure activity during isoflurane
anesthesia. Anesth Analg 64:367–368, 1985.
343.
Harrison JL: Postoperative seizures after isoflurane
anesthesia. Anesth Analg 65:1235–1236, 1986.
344.
Kofke WA, Young RSK, Davis P, et al: Isoflurane
for refractory status epilepticus: A clinical series. Anesthesiology 71:653–659,
1989.
345.
Komatsu H, Taie S, Endo S, et al: Electrical
seizures during sevoflurane anesthesia in two pediatric patients with epilepsy.
Anesthesiology 81:1535–1537, 1994.
346.
Haga S, Shima T, Momose K, et al: Anesthetic
induction of children with high concentrations of sevoflurane [in Japanese]. Jpn
J Anesthesiol 41:1951–1955, 1992.
347.
Kaisti K, Jaaskelainen S, Rinne JO, et al: Epileptiform
discharges during 2 MAC sevoflurane anesthesia in two healthy volunteers. Anesthesiology
91:1952–1955, 1999.
348.
Hisada K, Morioka T, Fukui K, et al: Electrocorticographic
activities in patients with temporal lobe epilepsy. J Neurosurg Anesthesiol 13:333–337,
2001.
349.
Hilty CA, Drummond JC: Seizure-like activity
on emergence from sevoflurane anesthesia. Anesthesiology 93:1357–1358, 2000.
350.
Terasako K, Ishii S: Postoperative seizure-like
activity following sevoflurane anesthesia. Anesth Analg 96:1239–1240, 2003.
351.
Nakanishi O, Ishikawa T, Imamura Y, Hirakawa T:
Inhibition of cerebral metabolic and circulatory responses to nitrous oxide by 6-hydroxydopamine
in dogs. Can J Anaesth 44:1008–1013, 1997.
352.
Field LM, Dorrance DE, Krzeminska EK, Barsoum
LZ: Effect of nitrous oxide on cerebral blood flow in normal humans. Br J Anaesth
70:154–159, 1993.
353.
Eng C, Lam AM, Mayberg TS, et al: The influence
of propofol with and without nitrous oxide on cerebral blood flow velocity and CO2
reactivity in humans. Anesthesiology 77:872–879, 1992.
354.
Henriksen HT, Jorgensen PB: The effect of nitrous
oxide on intracranial pressure in patients with intracranial disorders. Br J Anaesth
45:486–491, 1973.
355.
Moss E, McDowall DG: I.C.P increases with 50%
nitrous oxide in oxygen in severe head injuries during controlled ventilation. Br
J Anaesth 51:757–761, 1979.
356.
Pelligrino DA, Miletich DJ, Hoffman WE, Albrecht
RA: Nitrous oxide markedly increases cerebral cortical metabolic rate and blood
flow in the goat. Anesthesiology 60:405–412, 1984.
357.
Theye RA, Michenfelder JD: The effects of nitrous
oxide on canine cerebral metabolism. Anesthesiology 29:1119–1124, 1968.
358.
Phirman JR, Shapiro HM: Modification of nitrous
oxide-induced intracranial hypertension by prior induction of anesthesia. Anesthesiology
46:150–151, 1977.
359.
Misfeldt BB, Jorgensen PL, Rishoj M: The effect
of nitrous oxide and halothane upon the intracranial pressure in hypocapnic patients
with intracranial disorders. Br J Anaesth 46:853–858, 1974.
360.
Jung R, Reinsel R, Marx W, et al: Isoflurane
and nitrous oxide: Comparative impact on cerebrospinal fluid pressure in patients
with brain tumors. Anesth Analg 75:724–728, 1992.
361.
Hoffman WE, Miletich DJ, Albrecht RF: The effects
of midazolam on cerebral blood flow and oxygen consumption and its interaction with
nitrous oxide. Anesth Analg 65:729–733, 1986.
362.
Knudsen L, Cold GE, Holdgård HO, et al:
The effects of midazolam on cerebral blood flow and oxygen consumption. Interaction
with nitrous oxide in patients undergoing craniotomy for supratentorial tumors.
Anaesthesia 45:1016–1019, 1990.
363.
Manohar M, Parks C: Porcine regional brain and
myocardial blood flows during halothane-O2
and halothane-nitrous oxide
anesthesia: Comparisons with equipotent isoflurane anesthesia. Am J Vet Res 45:465–473,
1984.
364.
Manohar M, Parks CM: Porcine brain and myocardial
perfusion during enflurane anesthesia without and with nitrous oxide. J Cardiovasc
Pharmacol 6:1092–1101, 1984.
365.
Manohar M, Parks C: Regional distribution of
brain and myocardial perfusion in swine while awake and during 1.0 and 1.5 MAC isoflurane
anaesthesia produced without or with 50% nitrous oxide. Cardiovasc Res 18:344–353,
1984.
366.
Drummond JC, Scheller MS, Todd MM: The effect
of nitrous oxide on cortical cerebral blood flow during anesthesia with halothane
and isoflurane, with and without morphine, in the rabbit. Anesth Analg 66:1083–1089,
1987.
367.
Todd MM: The effects of PaCO2
on the cerebrovascular response to nitrous oxide in the halothane-anesthetized rabbit.
Anesth Analg 66:1090–1095, 1987.
368.
Kaieda R, Todd MM, Warner DS: The effects of
anesthetics and PaCO2
on the cerebrovascular,
metabolic, and electroencephalographic responses to nitrous oxide in the rabbit.
Anesth Analg 68:135–143, 1989.
369.
Strebel S, Kaufmann M, Anselmi L, Schaefer HG:
Nitrous oxide is a potent cerebrovasodilator in humans when added to isoflurane.
Acta Anesthesiol Scand 39:653–658, 1995.
370.
Algotsson L, Messeter K, Rosén I, Holmin
T: Effects of nitrous oxide on cerebral haemodynamics and metabolism during isoflurane
anaesthesia in man. Acta Anaesthesiol Scand 36:46–52, 1992.
371.
Baughman VL, Hoffman WE, Miletich DJ, Albrecht
RF: Cerebrovascular and cerebral metabolic effects of N2
O in unrestrained
rats. Anesthesiology 73:269–272, 1990.
372.
Roald OK, Forsman M, Heier MS, Steen PA: Cerebral
effects of nitrous oxide when added to low and high concentrations of isoflurane
in the dog. Anesth Analg 72:75–79, 1991.
373.
Wollman H, Alexander SC, Cohen PJ, et al: Cerebral
circulation during general anesthesia and hyperventilation in man. Anesthesiology
26:329–334, 1965.
374.
Tarkkanen L, Laitinen L, Johansson G: Effects
of d-tubocurarine on intracranial pressure and thalamic
electrical impedance. Anesthesiology 40:247–251, 1974.
375.
Basta SJ, Savarese JJ, Ali HH, et al: Histamine-releasing
potencies of atracurium, dimethyl tubocurarine and tubocurarine. Br J Anaesth 55:105S–106S,
1983.
376.
Basta SJ: Clinical pharmacology of mivacurium
chloride: A review. J Clin Anesth 4:153–163, 1992.
377.
Rosa G, Orfei P, Sanfilippo M, et al: The effects
of atracurium besylate (Tracrium) on intracranial pressure and cerebral perfusion
pressure. Anesth Analg 65:381–384, 1986.
378.
Schramm WM, Papousek A, Michalek-Sauberer A, et
al: The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical
patients. Anesth Analg 86:123–127, 1998.
379.
Rosa G, Sanfilippo M, Vilardi V, et al: Effects
of vecuronium bromide on intracranial pressure and cerebral perfusion pressure.
Br J Anaesth 58:437–440, 1986.
380.
Stirt JA, Maggio W, Haworth C, et al: Vecuronium:
Effect on intracranial pressure and hemodynamics in neurosurgical patients. Anesthesiology
67:570–573, 1987.
381.
Benthuysen JL, Kien ND, Quam DD: Intracranial
pressure increases during alfentanil-induced rigidity. Anesthesiology 68:438–440,
1988.
382.
Lanier WL, Milde JH, Michenfelder JD: The cerebral
effects of pancuronium and atracurium in halothane-anesthetized dogs. Anesthesiology
63:589–597, 1985.
383.
Lanier WL, Sharbrough FW, Michenfelder JD: Effects
of atracurium, vecuronium or pancuronium pretreatment on lignocaine seizure thresholds
in cats. Br J Anaesth 60:74–80, 1988.
384.
Tateishi A, Zornow MH, Scheller MS, Canfell PC:
Electroencephalographic effects of laudanosine in an animal model of epilepsy.
Br J Anaesth 62:548–552, 1989.
385.
Chapple DJ, Miller AA, Ward JB, Wheatley PL:
Cardiovascular and neurological effects of laudanosine. Br J Anaesth 59:218–225,
1987.
386.
Standaert FG: Magic bullets, science, and medicine.
Anesthesiology 63:577–578, 1985.
387.
Minton MD, Grosslight K, Stirt JA, Bedford RF:
Increases in intracranial pressure from succinylcholine: Prevention by prior nondepolarizing
blockade. Anesthesiology 65:165–169, 1986.
388.
Lanier WL, Milde JH, Michenfelder JD: Cerebral
stimulation following succinylcholine in dogs. Anesthesiology 64:551–559,
1986.
389.
Lanier WL, Iaizzo PA, Milde JH: Cerebral function
and muscle afferent activity following intravenous succinylcholine in dogs anesthetized
with halothane: The effects of pretreatment with a defasciculating dose of pancuronium.
Anesthesiology 71:87–95, 1989.
390.
Lanier WL, Iaizzo PA, Milde JH, Sharbrough FW:
The cerebral and systemic effects of movement in response to a noxious stimulus
in lightly anesthetized dogs. Anesthesiology 80:392–401, 1994.
391.
Stirt JA, Grosslight KR, Bedford RF, Vollmer D:
"Defasciculation" with metocurine prevents succinylcholine-induced increases in
intracranial pressure. Anesthesiology 67:50–53, 1987.
392.
Kovarik DW, Mayberg TS, Lam AM, et al: Succinylcholine
does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram
in patients with neurologic injury. Anesth Analg 78:469–473, 1994.
393.
Cutler RWP, Spertell RB: Cerebrospinal fluid:
A selective review. Ann Neurol 11:1–10, 1982.
394.
Artru AA: Effects of halothane and fentanyl on
the rate of CSF production in dogs. Anesth Analg 62:581–585, 1983.
395.
Artru AA: Effects of halothane and fentanyl anesthesia
on resistance to reabsorption of CSF. J Neurosurg 60:252–256, 1984.
396.
Artru AA: Isoflurane does not increase the rate
of CSF production in the dog. Anesthesiology 60:193–197, 1984.
397.
Artru AA: Effects of enflurane and isoflurane
on resistance to reabsorption of cerebrospinal fluid in dogs. Anesthesiology 61:529–533,
1984.
398.
Artru AA, Nugent M, Michenfelder JD: Enflurane
causes a prolonged and reversible increase in the rate of CSF production in the dog.
Anesthesiology 57:255–260, 1982.
399.
Maktabi MA, Elbokl FF, Faraci FM, Todd MM: Halothane
decreases the rate of production of cerebrospinal fluid. Anesthesiology 78:72–82,
1993.
400.
Artru AA: Rate of cerebrospinal fluid formation,
resistance to reabsorption of cerebrospinal fluid, brain tissue water content, and
electroencephalogram during desflurane anesthesia in dogs. J Neurosurg Anesthesiol
5:178–186, 1993.
401.
Artru AA: Dose-related changes in the rate of
cerebrospinal fluid formation and resistance to reabsorption of cerebrospinal fluid
following administration of thiopental, midazolam, and etomidate in dogs. Anesthesiology
69:541–546, 1988.
402.
Hatashita S, Hoff JT, Ishii S: Focal brain edema
associated with acute arterial hypertension. J Neurosurg 64:643–649, 1986.
403.
Sokrab T-EO, Johansson BB, Kalimo H, Olsson Y:
A transient hypertensive opening of the blood-brain barrier can lead to brain damage.
Acta Neuropathol 75:557–565, 1988.
404.
Mayhan WG: Disruption of blood-brain barrier
during acute hypertension in adult and aged rats. Am J Physiol 258:H1735–H1738,
1990.
405.
Johansson BB, Linder L-E: Do nitrous oxide and
lidocaine modify the blood-brain barrier in acute hypertension in the rat? Acta
Anaesth Scand 24:65–68, 1980.
406.
Forster A, Horn KV, Marshall LF, Shapiro HM:
Anesthetic effects on blood-brain barrier function during acute arterial hypertension.
Anesthesiology 49:26–30, 1978.
407.
Johansson B: Blood-brain barrier dysfunction
in acute arterial hypertension after papaverine-induced vasodilation. Acta Neurol
Scand 50:573–580, 1974.
408.
Smith AL, Marque JJ: Anesthetics and cerebral
edema. Anesthesiology 45:64–72, 1976.
409.
Modica PA, Tempelhoff R, White PF: Pro- and anticonvulsant
effects of anesthetics (Part I). Anesth Analg 70:303–315, 1990.
410.
Modica PA, Tempelhoff R, White PF: Pro- and anticonvulsant
effects of anesthetics (Part II). Anesth Analg 70:433–444, 1990.
411.
Kreisman NR, Magee JC, Brizzee BL: Relative hypoperfusion
in rat cerebral cortex during recurrent seizures. J Cereb Blood Flow Metab 11:77–87,
1991.
412.
Archer DP, McKenna JMA, Morin L, Ravussin P:
Conscious-sedation analgesia during craniotomy for intractable epilepsy: A review
of 354 consecutive cases. Can J Anaesth 35:338–344, 1988.
413.
Ford EW, Morrell F, Whisler WW: Methohexital
anesthesia in the surgical treatment of uncontrollable epilepsy. Anesth Analg 61:997–1001,
1982.
414.
Rockoff MA, Goudsouzian NG: Seizures induced
by methohexital. Anesthesiology 54:333–335, 1981.
415.
Musella L, Wilder BJ, Schmidt RP: Electroencephalographic
activation with intravenous methohexital in psychomotor epilepsy. Neurology 21:594–602,
1971.
416.
Bennett DR, Madsen JA, Jordan WS, Wiser WC: Ketamine
anesthesia in brain-damaged epileptics. Neurology 23:449–460, 1973.
417.
Ferrer-Allado T, Brechner VL, Dymond A, et al:
Ketamine-induced electroconvulsive phenomena in the human limbic and thalamic regions.
Anesthesiology 38:333–344, 1973.
418.
Steen P, Michenfelder JD: Neurotoxicity of anesthetics.
Anesthesiology 50:437–453, 1979.
419.
Hirshman CA, Krieger W, Littlejohn G, et al:
Ketamine-aminophylline-induced decrease in seizure threshold. Anesthesiology 56:464–467,
1982.
420.
Ghoneim MM, Yamada T: Etomidate: A clinical
and electroencephalographic comparison with thiopental. Anesth Analg 56:478–485,
1977.
421.
Laughlin TP, Newberg LA: Prolonged myoclonus
after etomidate anesthesia. Anesth Analg 64:80–82, 1985.
422.
Ebrahim ZY, DeBoer GE, Luders H, et al: Effect
of etomidate on the electroencephalogram of patients with epilepsy. Anesth Analg
65:1004–1006, 1986.
423.
Gancher S, Laxer KD, Krieger W: Activation of
epileptogenic activity by etomidate. Anesthesiology 61:616–618, 1984.
424.
Avramov MN, Husain MM, White PF: The comparative
effects of methohexital, propofol, and etomidate for electroconvulsive therapy.
Anesth Analg 81:596–602, 1995.
425.
Yeoman P, Hutchinson A, Byrne A, et al: Etomidate
infusions for the control of refractory status epilepticus. Intensive Care Med 15:255–259,
1989.
426.
Maekawa T, Tommasino C, Shapiro HM: Local cerebral
blood flow with fentanyl-induced seizures. J Cereb Blood Flow Metab 4:88–95,
1984.
427.
DeCastro J, VanDeWater A, Wouters L, et al: Comparative
study of cardiovascular neurological and metabolic side-effects of eight narcotics
in dogs. Acta Anaesthesiol Belg 30:5–9, 1979.
428.
Kofke WA, Garman RH, Tom WC, et al: Alfentanil-induced
hypermetabolism, seizure, and histopathology in rat brain. Anesth Analg 75:953–964,
1992.
429.
Kofke WA, Garman RH, Stiller RL, et al: Opioid
neurotoxicity: Fentanyl dose-response effects in rats. Anesth Analg 83:1298–1306,
1996.
430.
Rao TLK, Mummaneni N, El-Etr AA: Convulsions:
An unusual response to intravenous fentanyl administration. Anesth Analg 61:1020–1021,
1982.
431.
Safwat AM, Daniel D: Grand mal seizure after
fentanyl administration [letter]. Anesthesiology 59:78, 1983.
432.
Hoien A: Another case of grand mal seizure after
fentanyl administration [letter]. Anesthesiology 60:387–388, 1984.
433.
Murkin JM, Moldenhauer CC, Hug CC, Epstein CM:
Absence of seizures during induction of anesthesia with high dose fentanyl. Anesth
Analg 63:489–494, 1984.
434.
Smith NT, Westover CJ, Quinn M, et al: An electroencephalographic
comparison of alfentanil with other narcotics and with thiopental. J Clin Monit
1:236–244, 1985.
435.
Smith NT, Dec-Silver H, Sanford TJ, et al: EEGs
during high-dose fentanyl-, sufentanil-, or morphine-oxygen anesthesia. Anesth Analg
63:386–393, 1984.
436.
Cascino GD, So EL, Sharbrough FW, et al: Alfentanil-induced
epileptiform activity in patients with partial epilepsy. J Clin Neurophysiol 10:520–525,
1993.
437.
Astrup J, Symon L, Branston NM, Lassen NA: Cortical
evoked potential and extracellular K+
and H+
at critical levels
of brain ischemia. Stroke 8:52–57, 1977.
438.
Branston NM, Symon L, Crockard HA, Pasztor E:
Relationship between the cortical evoked potential and local cortical blood flow
following acute middle cerebral artery occlusion in the baboon. Exp Neurol 45:195–208,
1974.
439.
Jones TH, Morawetz RB, Crowell RM, et al: Thresholds
of focal cerebral ischemia in awake monkeys. J Neurosurg 54:773–782, 1981.
440.
Michenfelder JD, Sundt TM, Fode N, Sharbrough
FW: Isoflurane when compared to enflurane and halothane decreases the frequency
of cerebral ischemia during carotid endarterectomy. Anesthesiology 67:336–340,
1987.
441.
Carter LP, Yamagata S, Erspamer R: Time limits
on reversible cortical ischemia. Neurosurgery 12:620–623, 1983.
442.
Kaplan B, Brint S, Tanabe J, et al: Temporal
thresholds for neocortical infarction in rats subjected to reversible focal cerebral
ischemia. Stroke 22:1032–1039, 1991.
443.
Hossmann KA: Viability thresholds and the penumbra
of focal ischemia. Ann Neurol 36:557–365, 1994.
444.
Perkins WJ, Lanier WL, Schroeder DR, et al: Critical
regional cerebral blood flow determined using logistic regression analysis [abstract].
Anesthesiology 87:A173, 1997.
445.
Sundt TM, Sharbrough FW, Piepgras DG, et al:
Correlation of cerebral blood flow and electroencephalographic changes during carotid
endarterectomy. Mayo Clin Proc 56:533–543, 1981.
446.
Michenfelder JD, Sundt TM: Cerebral ATP and lactate
levels in the squirrel monkey following occlusion of the middle cerebral artery.
Stroke 2:319–326, 1971.
447.
Michenfelder JD, Theye RA: The effects of anesthesia
and hypothermia on canine cerebral ATP and lactate during anoxia produced by decapitation.
Anesthesiology 33:430–439, 1970.
448.
Siesjo BK: Pathophysiology and treatment of focal
cerebral ischemia. Part I: Pathophysiology. J Neurosurg 77:169–184, 1992.
449.
Benveniste H, Drejer J, Schousboe A, Diemer NH:
Elevation of the extracellular concentrations of glutamate and aspartate in rat
hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis.
J Neurochem 43:1369–1374, 1984.
450.
Furukawa K, Fu W, Li Y, et al: The actin-severing
protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability
to excitotoxicity in hippocampal neurons. J Neurosci 17:8178–8186, 1997.
